Key Takeaways Amgen launched AmgenNow, offering direct discounts starting with its cholesterol drug Repatha.Repatha's new $239 monthly price marks a nearly 60% cut from its U.S. list price.Amgen partnered with GoodRx to make Repatha available at this price across 70,000 pharmacies.Amgen (AMGN) announced the launch of a new direct-to-consumer (DTC) program called AmgenNow, which will offer significant discounts on its marketed drugs. The company has initiated this DTC program with its blockbuster cholesterol ...

The biotechnology company said that it has launched AmgenNow, a new direct-to-patient program, starting with its drug Repatha. ...

"Amgen is committed to finding new ways to help patients benefit from our medicines," said Murdo Gordon, executive vice president of Global Commercial Operations at Amgen. "Repatha has already helped more than 5 million patients, and the AmgenNow program will make it easier for uninsured patients or those who choose to pay out-of-pocket to access treatment. This will allow even more Americans at increased risk of major adverse cardiovascular events to benefit from this effective medicine." Beginning today ...